TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
WATCH
Manulife vs Sun Life He does not own any Life Co's now but are looking at them. Probably have more torque to upside with Manulife compared to Sun Life. He has not pulled the trigger on this yet, but is watching. He wants to see a little more direction on interest rates before they buy. They do well when interest rates go up.
BUY
Likes it. Canadian financials had a gift in Q4. The short report, he can't comment on it because he doesn't know enough. They've been executing well and buying back an insane number of shares. It's one of his largest positions. He liked their last quarter and they will continue buybacks.
WAIT
We are at a critical inflection point. He really likes the chart. He have had some strong volume over the last two days. Wait the next week or two and then it looks good. (Analysts’ price target is $28.00)
WAIT
The problem is that life insurance companies are having a tough time. You are dealing with a tough sector back drop.
DON'T BUY
He has SLF-T in this space. There is resistance at $22 that it has to punch through. It has a lot of resistance to get through. Look at others. See his Top Picks today. (Analysts’ price target is $28.00)
DON'T BUY
This will continue to be a random return opportunity. They earn a lot of money off capital markets returns. They're dealing with the hangover of low interest rates and mispriced products that'll hound them for many years. The street will always give MFC the benefit of the doubt, because they're large capital markets users. MFC isn't doing anything wrong, but are suffering obligations to their policy holders, which they do by selling new obligations in a slow-growing, low-return environment. Instead, look at BNS, RY or TD Bank.
COMMENT
Despite good numbers, the stock price hasn't risen much. He also doesn't understand why it hasn't gone up more. They've done well with Asian growth. Part of the drag comes from their long-term care business in the U.S.; they've reduced their exposire there. But what needs to happen is for MFC to show a couple of solid straight quarters to boost investor confidence.
BUY
Likes it long- and short-term. He'd buy it. A good company. It'll stay in the $18-24 channel, a wide channel.
DON'T BUY
Will it return to $28 within 12 months? He sold it in 2011 and hasn't returned. MFC never fully recovered from the Great Recession. What is their competitive advantage or moat? He prefer Power Corp among Canadian insurers and dividend payers. He avoid this sector, really.
DON'T BUY
Interest rates likely won't rise as high as previously expected. MFC has a history of not great operations in wealth management, lagging the industry. Also, all financial stocks in Canada have sold off. All this won't raise the stock price.
COMMENT
Is China hurting MFC-T? He owned MFC-T going into the 2008 crisis. But when the management announced they had taken on undue risk, he exited. They have never really reemerged from this. They were too exposed to equity markets back then, and decided to exit equities just as the market rallied to all time highs. He thinks there are better opportunities out there -- like SLF-T.
BUY

The short-seller raising the lawsuit is an old issue; he strongly doubts this lawsuit will hurt MFC. MFC is cheaper than its peers, trading at 8x. He sees 8% growth and dividend growth. Their only issue is their John Hancock purchase. They're growing in Asia. Won't hurt you long-term. Very cheap now. He likes it here.

BUY
He is encouraged by the new CEO's moves in the last year. They get a good chunk of earnings form wealth management in Asia. He could potentially add to it in the future.
PAST TOP PICK
(A Top Pick Jan 04/18, Down 20%) Weathered a perfect storm in 2018 including a short seller. Will discuss this in his Top Picks.
TOP PICK
Broader sector rotation into dividend stocks will benefit financials and lifecos. MFC has had a nice bounce off $18 and should perform well this year. He epxects an interest rate increase that will benefit MFC (he doesn't see an inverted yield curve this year). The short-seller allegations against them were really tenuous and should be resolved soon. MFC is trading at book value and pays a nearly 5% dividend. (Analysts’ price target is $28.25)
Showing 421 to 435 of 2,281 entries